This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
HK$0.11
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Total debt
Total debt on the balance sheet as of September 2023 : HK$0.14 Billion
According to Athersys's latest financial reports the company's total debt is HK$0.14 Billion. A company’s total debt is the sum of all current and non-current debts.
Athersys - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | HK$67.85 M | -10.89% |
| 2021-12-31 | HK$76.15 M | |
| 2016-12-31 | HK$7.78 M | 428.68% |
| 2015-12-31 | HK$1.47 M | 3.75% |
| 2014-12-31 | HK$1.41 M | 4.01% |
| 2013-12-31 | HK$1.36 M | 4.18% |
| 2012-12-31 | HK$1.3 M | |
| 2008-12-31 | N/A | -100% |
| 2007-12-31 | HK$13.9 M | |
| 2003-12-31 | HK$4.48 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | HK$450.41 B | 308,781.95% | 🇺🇸 USA |
 Pfizer PFE | HK$481.10 B | 329,829.48% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$402.20 B | 275,719.56% | 🇺🇸 USA |
 Moderna
MRNA | HK$5.84 B | 3,910.34% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$410.15 B | 281,172.54% | 🇺🇸 USA |
 United States Lime & Minerals USLM | HK$37.89 M | -74.01% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
 Merck MRK | HK$273.51 B | 187,465.27% | 🇺🇸 USA |
 Sanofi SNY | HK$178.73 B | 122,473.61% | 🇫🇷 France |